DANA MATHER: Open Payments
NPI 1689794257 · LITCHFIELD PARK, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,190 in 106 payments from 19 companies in 2025. Trend: 2023 $1,812 · 2024 $1,879 · 2025 $2,190
Food & beverage: $2,174Consulting: $16
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $368 |
| CSL Behring | 12 | $323 |
| GENZYME CORPORATION | 20 | $311 |
| Novartis Pharmaceuticals Corporation | 13 | $262 |
| GlaxoSmithKline, LLC. | 21 | $243 |
| Grifols USA, LLC | 6 | $132 |
| BioCryst US Sales Co., LLC | 6 | $130 |
| Regeneron Healthcare Solutions, Inc. | 5 | $105 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $51 |
| Pharming Healthcare, Inc. | 2 | $48 |
Products named: DUPIXENT, AIRSUPRA, NUCALA, Hizentra, Xembify, ORLADEYO, Andembry, XOLAIR.
Industry payments across AZ — which companies pay providers there.
